Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Net Cash Flow: 2020-2025

Historic Net Cash Flow for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -$14.1 million.

  • Caribou Biosciences' Net Cash Flow fell 138.67% to -$14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.9 million, marking a year-over-year increase of 71.07%. This contributed to the annual value of -$34.9 million for FY2024, which is 385.91% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Net Cash Flow is -$14.1 million, which was down 232.44% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Net Cash Flow ranged from a high of $305.8 million in Q3 2021 and a low of -$194.9 million during Q4 2021.
  • Over the past 3 years, Caribou Biosciences' median Net Cash Flow value was -$5.6 million (recorded in 2023), while the average stood at -$4.3 million.
  • Data for Caribou Biosciences' Net Cash Flow shows a peak YoY increase of 3,662.69% (in 2021) and a maximum YoY decrease of 2,167.74% (in 2021) over the last 5 years.
  • Caribou Biosciences' Net Cash Flow (Quarterly) stood at -$194.9 million in 2021, then surged by 87.82% to -$23.7 million in 2022, then tumbled by 122.75% to -$52.9 million in 2023, then surged by 70.36% to -$15.7 million in 2024, then tumbled by 138.67% to -$14.1 million in 2025.
  • Its Net Cash Flow stands at -$14.1 million for Q3 2025, versus -$4.2 million for Q2 2025 and $13.1 million for Q1 2025.